Jung Gu Park1, Gyoo-Sik Jung2, Jong Hyouk Yun1, Byung Chul Yun3, Sang Uk Lee3, Byung Hoon Han3, Ji Ho Ko4. 1. Department of Radiology, Kosin University College of Medicine, 262, Gamcheon-ro, Seo-gu, Busan, Korea. 2. Department of Radiology, Kosin University College of Medicine, 262, Gamcheon-ro, Seo-gu, Busan, Korea. gsjung240@gmail.com. 3. Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea. 4. Department of Radiology, Busan Medical Center, Busan, Korea.
Abstract
OBJECTIVES: To evaluate predictive factors for false-negative diagnosis of percutaneous forceps biopsies in patients suspected of having a malignant biliary obstruction METHODS: Two hundred seventy one consecutive patients with obstructive jaundice underwent percutaneous forceps biopsy. In each patient, three to five specimens (mean, 3.5 specimens) were collected from the lesion. The final diagnosis for each patient was confirmed with pathologic findings at surgery, additional histocytologic data, or clinical and radiologic follow-up. Univariate and multivariate logistic regression analysis was used to identify risk factors associated with false-negative diagnosis. RESULTS: One hundred ninety four of 271 biopsies resulted in correct diagnoses of malignancy, while 20 biopsy diagnoses were proved to be true-negative. There were 57 false-negative diagnoses and no false-positive diagnoses. The diagnostic performance of transluminal forceps biopsy in malignant biliary obstructions was as follows: sensitivity, 77.2%; specificity, 100%; and accuracy, 78.9%; positive predictive value, 100%, negative predictive value; 25.9%. Periampullary segment of common bile duct, intrahepatic bile duct and metastatic disease were the significant risk factors of false-negative diagnosis. CONCLUSIONS: Percutaneous forceps biopsy provides relatively high accuracy in the diagnosis of malignant biliary obstructions. The predictive factors of false-negative biopsy were determined to be biopsy site and origin of primary tumour. KEY POINTS: • Percutaneous forceps biopsy provides relatively high accuracy in diagnosis of malignant biliary obstructions. • The predictive factors of false-negative biopsy were biopsy site and origin of primary tumour. • The procedure-related complications were low.
OBJECTIVES: To evaluate predictive factors for false-negative diagnosis of percutaneous forceps biopsies in patients suspected of having a malignant biliary obstruction METHODS: Two hundred seventy one consecutive patients with obstructive jaundice underwent percutaneous forceps biopsy. In each patient, three to five specimens (mean, 3.5 specimens) were collected from the lesion. The final diagnosis for each patient was confirmed with pathologic findings at surgery, additional histocytologic data, or clinical and radiologic follow-up. Univariate and multivariate logistic regression analysis was used to identify risk factors associated with false-negative diagnosis. RESULTS: One hundred ninety four of 271 biopsies resulted in correct diagnoses of malignancy, while 20 biopsy diagnoses were proved to be true-negative. There were 57 false-negative diagnoses and no false-positive diagnoses. The diagnostic performance of transluminal forceps biopsy in malignant biliary obstructions was as follows: sensitivity, 77.2%; specificity, 100%; and accuracy, 78.9%; positive predictive value, 100%, negative predictive value; 25.9%. Periampullary segment of common bile duct, intrahepatic bile duct and metastatic disease were the significant risk factors of false-negative diagnosis. CONCLUSIONS: Percutaneous forceps biopsy provides relatively high accuracy in the diagnosis of malignant biliary obstructions. The predictive factors of false-negative biopsy were determined to be biopsy site and origin of primary tumour. KEY POINTS: • Percutaneous forceps biopsy provides relatively high accuracy in diagnosis of malignant biliary obstructions. • The predictive factors of false-negative biopsy were biopsy site and origin of primary tumour. • The procedure-related complications were low.
Authors: Yang K Chen; Mansour A Parsi; Kenneth F Binmoeller; Robert H Hawes; Douglas K Pleskow; Adam Slivka; Oleh Haluszka; Bret T Petersen; Stuart Sherman; Jacques Devière; Søren Meisner; Peter D Stevens; Guido Costamagna; Thierry Ponchon; Joyce A Peetermans; Horst Neuhaus Journal: Gastrointest Endosc Date: 2011-07-18 Impact factor: 9.427
Authors: S J Savader; F C Lynch; M G Radvany; B T Kudryk; R T Andrews; J F Geschwind; H Singh; M R Hamet Journal: J Vasc Interv Radiol Date: 1998 Sep-Oct Impact factor: 3.464
Authors: Anne Marie Augustin; Marcus Steingrüber; Friederika Fluck; Oliver Goetze; Thorsten Alexander Bley; Ralph Kickuth Journal: Diagn Interv Radiol Date: 2020-07 Impact factor: 2.630
Authors: Aldo Sebastián Oggero; Florencia Di Rocco; Pablo Ezequiel Huespe; Eduardo Mullen; Martín de Santibañes; Rodrigo Sanchez Claria; Oscar María Mazza; Juan Pekolk; Eduardo de Santibañes; Sung Ho Hyon Journal: Cardiovasc Intervent Radiol Date: 2021-05-04 Impact factor: 2.740
Authors: Daniel Pörner; Dominik J Kaczmarek; Dominik Heling; Annekristin Hausen; Raphael Mohr; Robert Hüneburg; Hanno Matthaei; Tim R Glowka; Steffen Manekeller; Hans-Peter Fischer; Marieta Toma; Jacob Nattermann; Christian P Strassburg; Maria A Gonzalez-Carmona; Tobias J Weismüller Journal: Sci Rep Date: 2020-10-15 Impact factor: 4.379